Short Interest in Hoth Therapeutics Inc (NASDAQ:HOTH) Increases By 65.2%

Hoth Therapeutics Inc (NASDAQ:HOTH) was the recipient of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 25,600 shares, a growth of 65.2% from the August 30th total of 15,500 shares. Based on an average trading volume of 12,700 shares, the short-interest ratio is currently 2.0 days. Approximately 0.7% of the shares of the company are short sold.

Shares of Hoth Therapeutics stock remained flat at $$4.20 during trading hours on Friday. The stock had a trading volume of 3,670 shares, compared to its average volume of 11,864. Hoth Therapeutics has a 52-week low of $3.83 and a 52-week high of $13.88. The business has a 50 day moving average price of $4.84 and a two-hundred day moving average price of $5.38. The company has a market cap of $42.29 million and a price-to-earnings ratio of -8.39.

Hoth Therapeutics (NASDAQ:HOTH) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.13) EPS for the quarter. Research analysts forecast that Hoth Therapeutics will post -0.39 EPS for the current year.

Hoth Therapeutics Company Profile

Hoth Therapeutics, Inc, a development stage biopharmaceutical company, focuses on developing targeted therapeutics for atopic dermatitis. It intends to use the BioLexa Platform to develop 2 topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures.

Featured Article: LIBOR

Receive News & Ratings for Hoth Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoth Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit